OKYO OKYO Pharma Ltd: institutional ownership and insider trading
19 funds reported holding $9.74M of OKYO Pharma Ltd in their latest 13F filings; in Q2 2026 funds net bought $156K, with 8 new positions and 1 funds selling out; over the last 12 months insiders bought $136K and sold $0 on the open market.
Famous investors holding OKYO
- Renaissance Technologies (Renaissance Technologies): $16.8K, 0.0% of the portfolio
Largest institutional holders of OKYO
- Woodline Partners LP — $5.48M
- Stonepine Capital Management, LLC — $1.29M
- Maven Securities LTD — $1.21M
- BALYASNY ASSET MANAGEMENT L.P. — $871K
- Opaleye Management Inc. — $563K
- UBS Group AG (UBS) — $82.5K
- XTX Topco Ltd — $56.7K
- CHOREO, LLC — $49.9K
- Quantinno Capital Management LP — $49.9K
- Cerity Partners LLC — $19.2K
Recent OKYO insider trades
- Jul 27, 2026: Patil Rajkumar V. bought 3,363 shares ($5.01K)
- Jul 22, 2026: Dempsey Robert John bought 15,000 shares ($23.1K)
- Jul 21, 2026: Mantelli Flavio bought 20,000 shares ($28.0K)
- Jul 21, 2026: Cerrone Gabriele M bought 22,500 shares ($32.6K)
5%+ owners
- Sirenia Capital Management LP: 7.7% (Schedule 13G, filed May 15, 2026)
- Woodline Partners LP: 7.0% (Schedule 13G, filed May 15, 2026)
Who owns the most OKYO stock?
The largest institutional holders of OKYO Pharma Ltd in the latest 13F filings are Woodline Partners LP ($5.48M), Stonepine Capital Management, LLC ($1.29M), Maven Securities LTD ($1.21M).
Are insiders buying or selling OKYO?
Over the last 12 months insiders bought $136K and sold $0 of OKYO Pharma Ltd stock on the open market (SEC Form 4).
Which famous investors own OKYO?
Renaissance Technologies.